Patent directory · USPTO A61K / A61P
Patents matching “PTC THERAPEUTICS, INC.”
149 pharma patents match "PTC THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 149 pharmaceutical patents matching "PTC THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12398140
Substituted pyrrolo [2,3-d]pyrimidines for treating familial dysautonomia
granted -
US 12384797
Thioeno[3,2-b] pyridin-7-amine compounds for treating familial dysautonomia
granted -
US 12384789
Compounds for treating Huntington's disease
granted -
US 12281083
2-substituted amino-naphth (1,2-d) imidazol-5-one compounds of pharmaceutically acceptable salts thereof
granted -
US 12139499
Heteroaryl compounds for treating Huntington's disease
granted -
US 12103926
Compounds for treating huntington's disease
granted -
US 12023335
Method for treating pancreatic cancer
granted -
US 11938101
Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
granted -
US 11858941
Heterocyclic and heteroaryl compounds for treating Huntington's disease
granted -
US 11840497
4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
granted -
US 11786486
Pharmaceutical compositions comprising 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione
granted -
US 11780839
Compounds for treating Huntington's disease
granted -
US 11753407
Compounds for treating spinal muscular atrophy
granted -
US 11746077
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders
granted -
US 11702646
Methods for modulating RNA splicing
granted -
US 11685746
Heteroaryl compounds for treating Huntington's disease
granted -
US 11680034
Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
granted -
US 11667596
2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disorders
granted -
US 11638706
Methods for treating Huntington's disease
granted -
US 11613538
Method of inhibiting or reducing a viral infection
granted -
US 11608501
Methods for modifying RNA splicing
granted -
US 11602567
Methods for modulating RNA splicing
granted -
US 11497736
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease
granted -
US 11458126
DHODH inhibitor for use in treating hematologic cancers
granted